Edelman, a global communications and marketing company, has named Alan Maine as its new senior director, it was reported yesterday.
Maine has earlier served as head of policy and public affairs at Pfizer UK, where he was responsible for government affairs and market access policy development activity, covering both corporate and therapy area public affairs. During his time at Pfizer, Maine also worked with industry associations on campaigns, policies and initiatives relating to access to medicines. Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals, later acquired by Pfizer, and has held other roles with Merck Sharpe & Dohme.
Kate Hawker, managing director for Edelman UK, said, 'We are very excited about Alan joining Edelman as he brings with him such great knowledge and insight of the complex challenges in the UK.'
Kibow Biotech receives AANP Corporation of the Year Award
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees